BioCentury
ARTICLE | Company News

Avalon, ImmunoGen deal

January 29, 2001 8:00 AM UTC

IMGN will develop antibody-based cancer therapeutics using gene targets provided by Avalon. IMGN will be responsible for development, manufacturing and marketing of resulting products. ...